PremiumThe FlyCidara Therapeutics price target raised to $74 from $53 at H.C. Wainwright Cidara Therapeutics price target raised to $66 from $59 at Citizens JMP Cidara Therapeutics Reports Positive Trial Results and Financial Growth PremiumCompany AnnouncementsCidara Therapeutics Announces $350 Million Stock Offering Cidara Therapeutics 7.95M share Secondary priced at $44.00 Cidara Therapeutics Suspends ATM Prospectus with Jefferies PremiumCompany AnnouncementsCidara Therapeutics Reports Positive Phase 2b Trial Results Morning News Wrap-Up: Monday’s Biggest Stock Market Stories! Cidara Therapeutics price target raised to $53 from $41 at H.C. Wainwright 
